共晶
药品
生物制药
药物开发
业务
药理学
医学
化学
生物技术
生物
有机化学
分子
氢键
作者
Xiaojuan Wang,Shouying Du,Rui Zhang,Xuedong Jia,Ting Yang,Xiaojian Zhang
标识
DOI:10.1016/j.ajps.2020.06.004
摘要
Recently, drug-drug cocrystal attracts more and more attention. It offers a low risk, low-cost but high reward route to new and better medicines and could improve the physiochemical and biopharmaceutical properties of a medicine by addition of a suitable therapeutically effective component without any chemical modification. Having so many advantages, to date, the reported drug-drug cocrystals are rare. Here we review the drug-drug cocrystals that reported in last decade and shed light on the opportunities and challenges for the development of drug-drug cocrystals.
科研通智能强力驱动
Strongly Powered by AbleSci AI